Introducing 

Prezi AI.

Your new presentation assistant.

Refine, enhance, and tailor your content, source relevant images, and edit visuals quicker than ever before.

Loading content…
Transcript

Perinatal HIV Exposure

Overview

BB James Smith

The Case

38 week AGA male born to a 29 yo G1P1 mother who is known to be HIV+

  • What pieces of information do you need to know?

  • What labs do you want for baby?

  • Does this baby require treatment, and if so what kind?

What maternal history do you need?

History

  • Timing of mother's diagnosis?

  • Was mother on antiviral treatment during pregnancy? Compliant?

  • Other known STIs?

Birth History?

Birth Hx

  • Gestational Age?

  • ROM timing?

  • C-section vs Vaginal?
  • Planned CS @ 38wks

  • Medications given prior to birth?
  • ZDV 3hrs prior

Maternal labs

  • Maternal HIV viral load

  • Maternal CD4+ count

  • Other infectious labs (RPR/TPAB, G/C, Hep B & C, GBS, Rubella)

Labs

Viral Suppression

  • Viral suppression is defined as <50 RNA copies/mL in maternal serum

  • The most important factor in mother-to-infant transmission

Why?

Newborn Labs

Newborn

  • CBC w/ diff

  • HIV DNA/RNA PCR

  • Urine CMV shell-vial and Culture

  • RPR and TPAB

  • Maternal Abs can remain in children up to 18 months of age

Treatment Overview

Treatment

  • All newborns with perinatal or unknown exposure need to be treated

  • Most experts encourage starting ASAP post-delivery

  • Treatment is a spectrum based on risk of transmission, stratified into 3 categories

Low Risk Exposure

Prophylaxis

  • Mothers who received ART during pregnancy

  • Sustained viral suppression near delivery no concerns related to adherence

  • Zidovudine for 4 weeks

Presumptive Treatment

High Risk

  • Mothers who received neither antepartum nor/only intrapartum ARV drugs

  • Treated mothers who have detectable viral loads near delivery, particularly vaginal delivery

  • Mothers w/ acute or primary HIV infection during pregnancy or breastfeeding

  • Mothers w/ unconfirmed HIV status who have at least one positive HIV test at delivery or postpartum

  • Newborns with positive HIV antibody test

HIV Infection

  • Positive HIV DNA/RNA test

  • Similar regimen as Presumptive therapy w/ extended duration

Proven

Triple Therapy

Regimen

Labs

Follow up

  • Monitoring for antiviral side effects
  • CBC, bilirubin

  • Repeat confirmatory HIV DNA/RNA
  • 14-21 days of life
  • 1-2 months of life
  • 4-6 months of life
  • 2-6 weeks post DC ART for high risk exposures

Ruled Out

Exclude

Considered HIV negative when:

  • 2 or more negative DNA/RNA PCRs
  • one test >/= 1 month age
  • second test >/= 4 months ag

  • 2 negative HIV Ab tests obtained >/= 6 months of age

  • Some also obtain HIV Ab test after 24 months to confirm loss of maternal Abs (previously Ab +)
Learn more about creating dynamic, engaging presentations with Prezi